| 1 |
34001306 | Therapeutic responses and predictors of low-dose interleukin-2 in systemic lupus erythematosus. | 2022 May |
1 |
| 2 |
34324715 | Engineering a safe monoclonal anti-human IL-2 that is effective in a murine model of food allergy and asthma. | 2022 Mar |
1 |
| 3 |
35193826 | Engineering of regulatory T cells by means of mRNA electroporation in a GMP-compliant manner. | 2022 Jun |
1 |
| 4 |
32662405 | Low-dose IL-2 effectively restored decreased regulatory T cells in patients with Behçet's disease. | 2021 Jul-Aug |
1 |
| 5 |
32800530 | NK cells and ILCs in tumor immunotherapy. | 2021 Aug |
1 |
| 6 |
33197573 | Regulatory T cell heterogeneity and therapy in autoimmune diseases. | 2021 May |
2 |
| 7 |
33512760 | Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis. | 2021 Aug |
3 |
| 8 |
33664462 | High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation. | 2021 Aug |
1 |
| 9 |
33828163 | Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity. | 2021 Apr 7 |
1 |
| 10 |
33830475 | IL-2/IL-2R Antibody Complex Enhances Treg-Induced Neuroprotection by Dampening TNF-α Inflammation in an In Vitro Stroke Model. | 2021 Dec |
2 |
| 11 |
33868284 | Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases. | 2021 |
6 |
| 12 |
33907514 | The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment. | 2021 |
1 |
| 13 |
33980663 | Suppression by Allogeneic-Specific Regulatory T Cells Is Dependent on the Degree of HLA Compatibility. | 2021 May 12 |
1 |
| 14 |
33995604 | Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis. | 2021 |
1 |
| 15 |
34036623 | Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC. | 2021 Nov |
1 |
| 16 |
34166564 | Genetic polymorphisms of regulatory T cell-related genes modulate systemic inflammation induced by viral hepatitis. | 2021 Nov |
1 |
| 17 |
34324441 | The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes. | 2021 Sep 22 |
1 |
| 18 |
34631716 | Bone Marrow Regulatory T Cells Are a Unique Population, Supported by Niche-Specific Cytokines and Plasmacytoid Dendritic Cells, and Required for Chronic Graft-Versus-Host Disease Control. | 2021 |
1 |
| 19 |
32311015 | IL-2 enhances ex vivo-expanded regulatory T-cell persistence after adoptive transfer. | 2020 Apr 28 |
2 |
| 20 |
32313719 | Overproduction of IL-2 by Cbl-b deficient CD4+ T cells provides resistance against regulatory T cells. | 2020 |
1 |
| 21 |
33013198 | Increased Serum Interleukin-2 Levels Are Associated with Abnormal Peripheral Blood Natural Killer Cell Levels in Patients with Active Rheumatoid Arthritis. | 2020 |
1 |
| 22 |
33072087 | Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination in vivo and Promote Dominance of FOXP3+ Tregs in vitro. | 2020 |
3 |
| 23 |
33134893 | An Adaptive Control Scheme for Interleukin-2 Therapy. | 2020 Nov 20 |
2 |
| 24 |
31781109 | Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp620 Risk Allele Drive the Expansion of FOXP3+ Regulatory T Cells and PD-1 Expression. | 2019 |
1 |
| 25 |
29861472 | Histone Modulation Blocks Treg-Induced Foxp3 Binding to the IL-2 Promoter of Virus-Specific CD8⁺ T Cells from Feline Immunodeficiency Virus-Infected Cats. | 2018 May 27 |
3 |
| 26 |
30048339 | Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. | 2018 Oct |
1 |
| 27 |
28382159 | A Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in Stroke. | 2017 |
1 |
| 28 |
28570278 | CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer. | 2017 Jun 2 |
1 |
| 29 |
26928938 | Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis. | 2016 Jul |
1 |
| 30 |
25548225 | Modulating DNA methylation in activated CD8+ T cells inhibits regulatory T cell-induced binding of Foxp3 to the CD8+ T Cell IL-2 promoter. | 2015 Feb 1 |
1 |
| 31 |
26433463 | Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors. | 2015 Sep 22 |
1 |
| 32 |
19238008 | Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells. | 2009 Feb-Mar |
1 |
| 33 |
17850588 | Agonistic anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining Foxp3 expression. | 2007 Oct |
1 |
| 34 |
15827965 | Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-)two to tango. | 2005 May |
1 |
| 35 |
16308572 | Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. | 2005 Dec |
3 |